vs
MEDIFAST INC(MED)与Utz Brands, Inc.(UTZ)财务数据对比。点击上方公司名可切换其他公司
Utz Brands, Inc.的季度营收约是MEDIFAST INC的4.5倍($341.0M vs $75.1M)。Utz Brands, Inc.同比增速更快(-3.1% vs -36.9%)。Utz Brands, Inc.自由现金流更多($16.5M vs $-6.6M)。过去两年Utz Brands, Inc.的营收复合增速更高(-1.5% vs -34.4%)
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业,该公司研发、分销并销售减重及健康相关产品,销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
Utz Brands, Inc.常简称为Utz,是总部位于美国宾夕法尼亚州汉诺威的休闲食品企业。该公司主打生产薯片、碱水脆饼等多种休闲食品,大部分产品以旗下品牌矩阵发售,同时也为仓储式会员店和批发商供应休闲零食。
MED vs UTZ — 直观对比
营收规模更大
UTZ
是对方的4.5倍
$75.1M
营收增速更快
UTZ
高出33.7%
-36.9%
自由现金流更多
UTZ
多$23.1M
$-6.6M
两年增速更快
UTZ
近两年复合增速
-34.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $75.1M | $341.0M |
| 净利润 | — | $2.3M |
| 毛利率 | 69.4% | 25.5% |
| 营业利润率 | -10.4% | 2.1% |
| 净利率 | — | 0.7% |
| 营收同比 | -36.9% | -3.1% |
| 净利润同比 | — | 108.3% |
| 每股收益(稀释后) | $-1.64 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MED
UTZ
| Q4 25 | $75.1M | — | ||
| Q3 25 | $89.4M | — | ||
| Q2 25 | $105.6M | — | ||
| Q1 25 | $115.7M | — | ||
| Q4 24 | $119.0M | $341.0M | ||
| Q3 24 | $140.2M | $365.5M | ||
| Q2 24 | $168.6M | $356.2M | ||
| Q1 24 | $174.7M | $346.5M |
净利润
MED
UTZ
| Q4 25 | — | — | ||
| Q3 25 | $-2.3M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $-772.0K | — | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $1.1M | $-2.2M | ||
| Q2 24 | $-8.2M | $19.8M | ||
| Q1 24 | $8.3M | $-4.0M |
毛利率
MED
UTZ
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | 25.5% | ||
| Q3 24 | 75.4% | 26.9% | ||
| Q2 24 | 73.2% | 26.7% | ||
| Q1 24 | 72.8% | 25.5% |
营业利润率
MED
UTZ
| Q4 25 | -10.4% | — | ||
| Q3 25 | -4.6% | — | ||
| Q2 25 | -1.0% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | 0.6% | 2.1% | ||
| Q3 24 | 1.5% | 5.3% | ||
| Q2 24 | -4.7% | 6.3% | ||
| Q1 24 | 4.5% | 2.8% |
净利率
MED
UTZ
| Q4 25 | — | — | ||
| Q3 25 | -2.5% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | -0.7% | — | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | 0.8% | -0.6% | ||
| Q2 24 | -4.8% | 5.6% | ||
| Q1 24 | 4.8% | -1.2% |
每股收益(稀释后)
MED
UTZ
| Q4 25 | $-1.64 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.08 | $0.04 | ||
| Q3 24 | $0.10 | $-0.03 | ||
| Q2 24 | $-0.75 | $0.23 | ||
| Q1 24 | $0.76 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $56.1M |
| 总债务越低越好 | — | $768.6M |
| 股东权益账面价值 | $198.9M | $696.9M |
| 总资产 | $248.0M | $2.7B |
| 负债/权益比越低杠杆越低 | — | 1.10× |
8季度趋势,按日历期对齐
现金及短期投资
MED
UTZ
| Q4 25 | $167.3M | — | ||
| Q3 25 | $173.5M | — | ||
| Q2 25 | $162.7M | — | ||
| Q1 25 | $164.6M | — | ||
| Q4 24 | $162.3M | $56.1M | ||
| Q3 24 | $170.0M | $64.9M | ||
| Q2 24 | $163.5M | $66.6M | ||
| Q1 24 | $156.4M | $47.0M |
总债务
MED
UTZ
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $768.6M | ||
| Q3 24 | — | $780.8M | ||
| Q2 24 | — | $797.6M | ||
| Q1 24 | — | $756.9M |
股东权益
MED
UTZ
| Q4 25 | $198.9M | — | ||
| Q3 25 | $214.7M | — | ||
| Q2 25 | $216.0M | — | ||
| Q1 25 | $211.0M | — | ||
| Q4 24 | $210.1M | $696.9M | ||
| Q3 24 | $207.3M | $685.7M | ||
| Q2 24 | $205.3M | $686.0M | ||
| Q1 24 | $211.0M | $671.1M |
总资产
MED
UTZ
| Q4 25 | $248.0M | — | ||
| Q3 25 | $268.2M | — | ||
| Q2 25 | $269.3M | — | ||
| Q1 25 | $280.0M | — | ||
| Q4 24 | $284.2M | $2.7B | ||
| Q3 24 | $291.2M | $2.6B | ||
| Q2 24 | $293.5M | $2.7B | ||
| Q1 24 | $302.8M | $2.6B |
负债/权益比
MED
UTZ
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 1.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $54.2M |
| 自由现金流经营现金流 - 资本支出 | $-6.6M | $16.5M |
| 自由现金流率自由现金流/营收 | -8.8% | 4.8% |
| 资本支出强度资本支出/营收 | 1.8% | 11.1% |
| 现金转化率经营现金流/净利润 | — | 23.67× |
| 过去12个月自由现金流最近4个季度 | $1.2M | $7.6M |
8季度趋势,按日历期对齐
经营现金流
MED
UTZ
| Q4 25 | $-5.3M | — | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | $3.4M | — | ||
| Q4 24 | $-4.9M | $54.2M | ||
| Q3 24 | $9.1M | $52.2M | ||
| Q2 24 | $13.1M | $8.9M | ||
| Q1 24 | $7.3M | $-9.1M |
自由现金流
MED
UTZ
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $10.8M | — | ||
| Q2 25 | $-4.8M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $-7.2M | $16.5M | ||
| Q3 24 | $7.7M | $29.1M | ||
| Q2 24 | $11.1M | $-15.3M | ||
| Q1 24 | $5.4M | $-22.7M |
自由现金流率
MED
UTZ
| Q4 25 | -8.8% | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | -4.5% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | -6.1% | 4.8% | ||
| Q3 24 | 5.5% | 8.0% | ||
| Q2 24 | 6.6% | -4.3% | ||
| Q1 24 | 3.1% | -6.5% |
资本支出强度
MED
UTZ
| Q4 25 | 1.8% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.9% | 11.1% | ||
| Q3 24 | 1.0% | 6.3% | ||
| Q2 24 | 1.1% | 6.8% | ||
| Q1 24 | 1.1% | 3.9% |
现金转化率
MED
UTZ
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 23.67× | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图